Houston-based March Biosciences, an emerging clinical stage biotechnology company committed to combating challenging cancers and other diseases, announced that the US Food and Drug Administration (FDA) granted orphan drug designation to MB-105...
Quantum-Si Incorporated, the protein sequencing firm, and IDEX Health & Science, LLC, announced a collaboration to develop and manufacture the optics module for Quantum-Si's innovative proteomics platform, Proteus. IDEX Health & Science, LLC...
After a successful edition of the maiden award ceremony in 2024, Eminence is thrilled to announce the Pharma Quality Excellence Awards 2025, taking place on April 25th, 2025, in conjunction with the 5th Annual Pharma GMP and Quality Management 2025
The pharmaceutical industry is undergoing rapid transformation, with an increasing focus on quality, compliance, and innovation in manufacturing processes. In this context, Eminence Business Media has announced 5th Annual Pharma GMP and Quality Manag
Bajaj Healthcare announced that it has obtained approval from the Drug Controller General of India (DCGI) to produce both the API and drug formulation of Pimavanserin. Pimavanserin is an atypical antipsychotic utilized to treat hallucinations and...
Granules India Limited, an integrated Indian pharma firm, declared that its wholly-owned foreign subsidiary, Granules Pharmaceuticals, Inc. (GPI), has obtained final approval from the U.S. Food & Drug Administration (USFDA) for its Abbreviated New...
NATCO Pharma announced that it has obtained approval for its ANDA concerning Everolimus tablets for oral suspension (TFOS), a generic equivalent of AFINITOR DISPERZ from Novartis Pharmaceutical Corporation. Breckenridge Pharmaceutical, Inc, the...
Neurocrine Biosciences, Inc., a prominent biopharmaceutical firm concentrating on neuroscience, revealed the commencement of a phase 3 trial to assess the efficacy, safety, and tolerability of osavampator (previously known as NBI-1065845)...
Beckman Coulter Diagnostics, a worldwide frontrunner in clinical diagnostics, declared that the US Food and Drug Administration (FDA) has awarded Breakthrough Device Designation to Beckman Coulter's Access p-Tau217/ß-Amyloid 1-42 plasma ratio...
Global pharmaceutical giant Lupin Limited has revealed that it has gained approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA) for Ipratropium Bromide Nasal Solution (Nasal Spray)...
, CDSCO.jpg)
